Scientists at Nagoya University in Japan studied what happens when macrophages—a type of immune cell—encounter dying cancer cells in tumors and discovered a mechanism that accelerates tumor growth.

During early drug development and preclinical development, researchers use in vitro cultured lymphocytes to induce cytokine ...

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...

Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment.

A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...

Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...

Researchers have discovered how an inflammatory feedback loop initiated as cancer cells die helps cancer hijack immune responses in order to spread.

Dr Dinesh Pendharkar highlights how CAR T–cell therapy is reshaping cancer care in India by equipping the immune system with ...

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan) , led by Nadia Coltella and Luigi Naldini, has ...

The growing prevalence of chronic diseases is a major factor driving revenue growth in the natural killer (NK) cell ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...